PEOPLE
50
While other organisations have followed our lead and are now pursuing similar concepts , Rani ’ s early start in the pursuit of a pill to replace painful injections has secured our position as a pioneer of robotic pills . We have conducted more than 100 preclinical studies proving that our technology works – and delivers the same amount of drug as a subcutaneous injection . We have also begun testing in humans — specifically testing the safety and tolerability of the RaniPill™ capsule without the drug . Those studies were successful , demonstrating that the RaniPill™ capsule deployed with no feeling or perception by the subjects and the remnants passed out of the body . We are moving towards human testing with the RaniPill™ capsule loaded with a drug ( Octreotide , a drug used for the treatment of acromegaly ) this year .
Given your experience as a leader of business units and enterprises , how do you ensure that you attract , utilise and retain top talent ? It is our intent to attract and retain innovative thinkers to help us build
SEPTEMBER 2019